These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19578603)

  • 1. Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism.
    Sousa AA; Kronit HS; Neves Fde A; Amato AA
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):383-6. PubMed ID: 19578603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.
    Wang D; Wang Y
    Medicine (Baltimore); 2018 Apr; 97(14):e0318. PubMed ID: 29620657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothyroidism is a predisposing factor for fenofibrate-induced rhabdomyolysis--patient report and literature review.
    Satarasinghe RL; Ramesh R; Riyaaz AA; Gunarathne PA; de Silva AP
    Drug Metabol Drug Interact; 2007; 22(4):279-83. PubMed ID: 18447003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism.
    Clouâtre Y; Leblanc M; Ouimet D; Pichette V
    Nephrol Dial Transplant; 1999 Apr; 14(4):1047-8. PubMed ID: 10328516
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report.
    Kiskac M; Zorlu M; Cakirca M; Karatoprak C; Peru C; Erkoc R; Yavuz E
    Indian J Pharmacol; 2013; 45(3):305-6. PubMed ID: 23833382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate-induced rhabdomyolysis in a patient with stage 4 chronic renal failure due to diabetes mellitus.
    Soyoral YU; Canbaz ET; Erdur MF; Emre H; Begenik H; Erkoc R
    J Pak Med Assoc; 2012 Aug; 62(8):849-51. PubMed ID: 23862266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid myopathy disclosed by a fibrate].
    Schlienger JL; Goichot B; Grunenberger F; Pradignac A
    Rev Med Interne; 1997; 18(2):169-70. PubMed ID: 9092037
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism.
    Kursat S; Alici T; Colak HB
    Clin Nephrol; 2005 Nov; 64(5):391-3. PubMed ID: 16312269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rhabdomyolysis induced by fenofibrate monotherapy].
    Archambeaud-Mouveroux F; Lopez S; Combes C; Lassandre S; Amaniou M; Teissier MP; Galinat S
    Rev Med Interne; 2006 Jul; 27(7):573-4. PubMed ID: 16716459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.
    Ireland JH; Eggert CH; Arendt CJ; Williams AW
    Ann Intern Med; 2005 Jun; 142(11):949-50. PubMed ID: 15941707
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rhabdomyolysis with acute renal insufficiency: role of the association of fibrate and hypothyroidism].
    Fredenrich A; Sadoul JL; Jambou P; Vinti H
    Rev Med Interne; 1991; 12(3):238. PubMed ID: 1896719
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute renal failure due to fenofibrate monotherapy.
    Usküdar Cansu D; Yaşar NS; Korkmaz C
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):371-2. PubMed ID: 21592934
    [No Abstract]   [Full Text] [Related]  

  • 13. Fenofibrate monotherapy induced rhabdomyolysis.
    Barker BJ; Goodenough RR; Falko JM
    Diabetes Care; 2003 Aug; 26(8):2482-3. PubMed ID: 12882895
    [No Abstract]   [Full Text] [Related]  

  • 14. Fenofibrate-induced rhabdomyolysis in a patient with chronic renal failure due to nephrotic syndrome: a rare case report.
    Erdur FM; Soyoral YU; Emre H; Begenik H; Canbaz ET; Erkoc R
    Clin Biochem; 2012 Jan; 45(1-2):162-4. PubMed ID: 22019952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients.
    Unal A; Torun E; Sipahioglu MH; Tokgoz B; Kaya MG; Oymak O; Utas C
    Intern Med; 2008; 47(11):1017-9. PubMed ID: 18520113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.
    Cetinkaya R; Uyanik A; Yildirim R; Bilen Y; Keles M
    Indian J Med Sci; 2008 Nov; 62(11):458-9. PubMed ID: 19265237
    [No Abstract]   [Full Text] [Related]  

  • 17. Simvastatin, fenofibrate, and rhabdomyolysis.
    Jacob SS; Jacob S; Williams C; Deeg MA
    Diabetes Care; 2005 May; 28(5):1258. PubMed ID: 15855605
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of adverse events with fibrates.
    Alsheikh-Ali AA; Kuvin JT; Karas RH
    Am J Cardiol; 2004 Oct; 94(7):935-8. PubMed ID: 15464682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 68-year old male presenting with rhabdomyolysis-associated acute kidney injury following concomitant use of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate and pravastatin/fenofibrate: a case report.
    Suttels V; Florence E; Leys J; Vekemans M; Van den Ende J; Vlieghe E; Kenyon C
    J Med Case Rep; 2015 Sep; 9():190. PubMed ID: 26347243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis.
    Tahmaz M; Kumbasar B; Ergen K; Ure U; Karatemiz G; Kazancioglu R
    Ren Fail; 2007; 29(7):927-30. PubMed ID: 17994463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.